-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 25, Bayer HealthCare Co.
, Ltd.
and Ali Health signed a strategic cooperation agreement.
The two parties will focus on exploring the patient management business of anticoagulant drugs, and will develop in-depth development in multiple fields such as new drug retail, patient education, and online medical services.
Cooperation
.
Patients with atrial fibrillation, pulmonary thrombosis, knee joint replacement and other patients need long-term use of anticoagulant drugs, but many patients' awareness of related medication matters needs to be improved
.
Therefore, the cooperation between Bayer and Alibaba Health will take the lead in the long-term medication management of patients with anticoagulant drugs, and jointly use digital means to provide comprehensive guidance to drug users through pharmacist guidance, telephone follow-up, medication management, and professional content science popularization.
"Currently, the industry is facing challenges in patient management.
First, as a service provider, it ignores the perceptual needs of patients and their families.
Second, it focuses on single products and single scenarios in disease management, and ignores the integrity of the medical service chain
.
" Zhang Jingchuan, Senior Director of National Retail Management of Bayer Prescription Drugs Division, said: “Bayer is a global leader in the field of cardiovascular diseases such as anticoagulation and antithrombosis
In addition, relying on the ecological layout, self-operated links and warehousing system in the Alibaba health field, the two parties will also cooperate in Internet hospital projects and new drug retail business to jointly explore new online prescription circulation models in order to realize the line of chronic disease patients.
On-site service and full management
.
In the future, the two parties also plan to jointly build a flagship store for the pharmaceutical business brand to better provide medical services to patients
"Alibaba Health hopes to be an expert in taking care of the health of you and your family, and at the same time as a partner and friend who develops hand in hand with pharmaceutical companies
.
" Shen Difan, chief operating officer of Alibaba Health, said that this cooperation with Bayer will continue to explore online medicine for various diseases.
Ms.
Luo Xiaojie, Senior Vice President of the Prescription Drug Division of Bayer Group, also expressed expectations for this cooperation between the two parties: "Bayer and Alibaba Health have always maintained close cooperation
.
This cooperation is a new beginning and has forward-looking significance for the future.
Bayer has previously cooperated with Alibaba Health in the fields of global marketing, health care product retail, and new drug listing
.
In April of this year, Alibaba Health teamed up with the top 100 well-known pharmaceutical companies to form the "Tmall Good Medicine Alliance" to provide alliance members with a "Tmall Good Medicine" IP traffic sharing platform, a digital marketing platform for pharmaceutical companies, a medication service platform, and a next-day delivery of medicines.
Five platform-level services including logistics platform and charity drug donation platform
